Xylem Q2 2026 EPS Beats Consensus; Shares Trade Near 1-Year Low
Xylem's Q2 2026 EPS of $1.46 exceeded estimates, while revenue hit $2.34 billion. The stock trades at $107.58, near its one-year low.
Key points
- Xylem Q2 2026 EPS of USD 1.46 beat consensus estimates of USD 1.34 by USD 0.12.
- Revenue reached USD 2.34 billion, up 1.5 percent year over year, with a net margin of 11.15 percent.
- Shares trade at USD 107.58, near the one-year low, while full-year EPS guidance is set at USD 5.55-5.70.
Xylem Inc. reported second-quarter 2026 earnings per share of USD 1.46, surpassing the consensus estimate of USD 1.34 by USD 0.12. Revenue reached USD 2.34 billion, matching market expectations and representing a 1.5 percent year-over-year increase. As of September 20, 2026, the company’s shares traded at USD 107.58 on the NYSE, a level that sits just above the one-year low of USD 105.29.
The company’s profitability metrics remained stable during the quarter, with a net margin of 11.15 percent and a return on equity of 11.77 percent. According to data from ad-hoc-news.de, these figures indicate that Xylem converted roughly one-ninth of its sales into net income, reflecting a balance between growth initiatives and cost management in the current industrial environment.
Full-year guidance remains achievable
Xylem set its full-year 2026 earnings guidance at a range of USD 5.55 to USD 5.70 per share. Analysts currently project full-year EPS of USD 5.66, which aligns closely with the midpoint of the company’s guided range. This proximity suggests that the market views the forward outlook as broadly attainable based on the strong second-quarter performance.
Dividend payout supports shareholder returns
The company maintains a quarterly dividend of USD 0.43 per share, resulting in an annualized yield of approximately 1.6 percent at current price levels. With a payout ratio of 40.95 percent, Xylem retains nearly 60 percent of its earnings for reinvestment, balance sheet strengthening, or other corporate purposes while continuing to distribute cash to investors.
Valuation sits near one-year lows
Shares opened at USD 107.58, reflecting a trading range where the one-year high stands at USD 154.27. The current price is more than USD 40 below that peak, indicating significant consolidation after earlier strength. Investors are weighing the earnings beat and steady revenue growth against a share price that remains depressed relative to historical highs.
